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Abstract
During progression from benign nevus to vertical growth phase melanoma, melanocytes acquire the ability to invade into
the dermis. This process requires rupture of the basal lamina and dissolution of dermal type I collagen. Metastases-derived
human melanoma MIM cells have an invasive ability in vitro which is dependent on metalloproteinases. In the present study
 .we analysed the role of type I collagenase MMP-1 in melanoma invasion using MIM cells in which the constitutive
expression of MMP-1 was suppressed by stable transfection with a plasmid vector expressing a 777 bp antisense fragment
of MMP-1 genomic DNA. Two clones were isolated in which MMP-1 mRNA expression was blocked by 90–96% with a
corresponding loss in protein synthesis. In their morphological appearance and growth rate in vitro these cells were
indistinguishable from wild type cells or control cells transfected with the same vector expressing the MMP-1 fragment in
 .the sense orientation. Their mRNA and protein levels for type IV collagenase MMP-2 were unchanged as assessed by
Northern and Western blot analyses and by gelatin zymography. However, when the invasive ability of the cells was
measured, we found that in addition to type I collagen, invasion through type IV collagen and a reconstituted, type IV
 .collagen-containing basement membrane Matrigel were also significantly inhibited as compared to normal or sense-trans-
fected cells. The results indicate that despite the presence of functional MMP-2, degradation of type IV collagen matrices by
the melanoma cells was dependent on expression of MMP-1. q 1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cellular invasion is required for many physio-
logical processes both normal e.g., matrix remod-
.  . w xelling and pathological e.g., tumor metastasis 1 .
Metastasis is a complex multistep process during
which tumor cells invade through different extracellu-
) Corresponding author. Fax: q1 414 3988361.
 .lar matrices ECM such as basement membrane and
connective tissue and give rise to new foci at sites
distant from the primary tumor.
The ECM is a complex structure composed of
collagen, glycoproteins and proteoglycans forming a
dense meshwork normally impenetrable to migrating
w xcells 2–4 . Tumor cells can invade the ECM through
the upregulated expression and release of hydrolytic
w xenzymes which can solubilize this matrix 1,5 . The
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enzymes mediating ECM degradation belong to sev-
eral known classes of proteinases including the metal-
 .loproteinases MMPs and the serine, cysteine and
w xaspartic proteinases 1,2 . Among the metallopro-
teinases, several collagenases have been identified
 .including interstitial collagenase MMP-1 which de-
grades types I, II and III collagen and two type IV
collagenases; a 72 kDa gelatinase designated MMP-2
and a 92 kDa gelatinase designated MMP-9 which
can degrade types IV and V and denatured collagen
w x2,6 . Another metalloproteinase implicated in metas-
 .tasis is stromelysin-1 MMP-3 which can degrade
fibronectin, laminin, proteoglycans and type IV colla-
w xgen 7 .
w xThe MMPs have similar primary structures 8,9
and are secreted in a zymogen form which can be
activated by a ‘cysteine switch’ mechanism resulting
in autolytic cleavage at the N-terminus of the proen-
w xzyme 10 . Their extracellular activity is regulated by
endogenous tissue inhibitors of metalloproteinases of
which three TIMP-1, TIMP-2 and TIMP-3 have been
w xidentified to date 11 . The net proteolytic activity
associated with the cells reflects therefore the balance
between the activities of the enzymes and their in-
w xhibitors 12,13 . MMPs have been implicated in the
invasion and metastasis of different malignancies
w x w x14–16 including melanoma 17–19 . Much of the
available evidence implicates MMP-2 and MMP-9 in
w xtumor invasion 20–22 . Little is presently known,
however, about the contribution of MMP-1 to this
w xprocess 16,18 .
In the present study we assessed the invasive
ability of human melanoma cells in which MMP-1
expression was suppressed by stable transfection with
a plasmid vector expressing MMP-1 DNA in the
antisense orientation. Cell invasion was measured
using filters coated with reconstituted basement
 .membrane Matrigel , type I and type IV collagen.
Our evidence indicates that the invasiveness of these
cells through all three matrices required MMP-1 ex-
pression.
2. Materials and methods
2.1. Cell lines
The melanoma MIM line was established from an
inguinal lymph node metastasis of a male melanoma
w xpatient, as we previously described 23 . Cells were
grown as a monolayer culture in RPMI 1640 medium
supplemented with 5% heat-inactivated fetal bovine
 . serum FCS , 2 mM glutamine, penicillin 100
.  .unitsrml and streptomycin 100 mgrml . Once
weekly the monolayers were dispersed with a 0.5
mM EDTA solution and the cells reseeded at a
dilution of 1:5.
2.2. Plasmid construction and transfection
A 777 bp genomic DNA fragment of MMP-1 was
 .generated by the polymerase chain reaction PCR
performed on a crude lysate of normal lung fibrob-
lasts. The reaction ran for 30 cycles in an automated
 .thermal cycler Perkin-ElmerrCetus using a 608C
annealing temperature and standard conditions for
denaturation and extension. The primers correspond-
 .  .ing to bases 1–25 primer 1 and 246–278 primer 2
w xof the human collagenase cDNA 24 were synthe-
sized using the Applied Biosystem DNA Synthesizer.
The PCR product spanning the entire noncoding se-
quence, exon 1, intron 1 and a 36 bp fragment of
w xexon 2 25 was inserted into the EcoR1 multiple
 .cloning site of the pSVK3 plasmid vector Pharmacia
in either the sense of antisense orientations relative to
the SV40 origin and early promoter regions. The
constructs were checked for fidelity by restriction
enzyme mapping. The aminoglycoside phosphotrans-
 .ferase neo gene was then cloned into the Hpa1
restriction site of the same plasmid under the control
of the SV40 early promoter.
Cell transfection was performed by electroporation
 .using the ElectroPorator Apparatus Invitrogen at
 .200 V. The plasmid DNA 5 mg was linearized at
the PvuII restriction site and mixed with 106 cells
suspended in 400 ml Hepes-buffered saline and kept
on ice. The transfected cells were cultured in RPMI
medium containing 5% FCS and antibiotics and sup-
plemented from day 2 onward with 200 mgrml G418
 .Geneticin; Gibco . G418-resistant clones were iso-
lated 2–3 weeks later.
2.3. RNA extraction and Northern blot analysis
 .Cell monolayers at 80% confluency were
scrapped, centrifuged and the pellets lysed with an
NP-40 lysis buffer 0.15 M NaCl containing 1 mM
.Tris-HCl, pH 7.5, 1.5 mM MgC1 and 0.5% NP-402
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for 5 min on ice. The lysate was cleared by centrifu-
gation and the supernatant mixed with urea buffer
0.35 M NaC1 with 10 mM Tris-HCl, pH 7.5, 10 mM
.EDTA, 7 M urea and 1% SDS and phenolrchloro-
 .formrisoamyl alcohol 50:48:2 and left overnight at
y808C. RNA was precipitated from the aqueous
phase with absolute ethanol and stored at y208C.
 .For Northern blot analysis, RNA 15 mgrlane
was separated on 1% agarose-formaldehyde gels,
transferred onto Hybond-N nylon membranes
 .Amersham by capillary action in 20=SSC and
covalently cross-linked by UV irradiation. Prehy-
bridization and hybridization of the membranes were
carried out at 428C. The filters were hybridized either
with a synthetic oligonucleotide probe, corresponding
w xto bases 246–278 of type I collagenase cDNA 24
which was end-labeled with 32P-ATP or with a 1.1
kb type IV collagenase cDNA fragment kindly pro-
.vided by Dr. W. Stetler-Stevenson, NIH which was
labeled by the random primer extension labeling sys-
 . 32 32tem DuPont using P-CTP. A P-ATP end-labeled
18S oligonucleotide probe was used as a control for
RNA loading. The hybridized filters were washed
twice at 558C for 30 min with either 6=SSPE
 .filters probed with oligonucleotides or 0.1=SSC
 .containing 0.1% SDS filters probed with cDNA and
autoradiographed at y808C. The relative amounts of
mRNA transcripts were analysed by laser densitom-
etry using an LKB Ultroscan XL Enhanced laser
densitometer and normalized relative to the 18S rRNA
controls.
2.4. Preparation of conditioned media
Cultures were grown to 80% confluency in 6-well
plates, washed twice with serum-free RPMI and cul-
tured in serum-free RPMI for 72 h. The supernatants
were collected, cells and debris removed by centrifu-
gation and filtration and the cleared supernatants
dialyzed against a collagenase buffer 1 mM Tris-HCl,
.pH 7.6, with 1 mM CaC1 for 24 h, aliquoted,2
concentrated by freeze-drying at y1208C using a
 .cooling trap HETOTRAP CT 110 and stored at
y208C until used.
2.5. Western blot analysis
Western blot analysis was performed essentially as
w xwe described previously 26 . Briefly, serum-free
 .conditioned media 50=concentrated were sepa-
rated on a 10% SDS-polyacrylamide gel and the
proteins electrophoretically transferred onto nitro-
 .cellulose filters 0.2 mm; Schleicher and Schuell .
The blots were probed either with a mouse mono-
clonal antibody to MMP-1 Cedarlane Laboratories,
. w xHornby, Ontario 27 or with a rabbit antiserum to
MMP-2 a kind gift from Dr. William Stetler-Steven-
.son, NIH . Alkaline phosphatase-conjugated affinity
purified goat anti-mouse IgG or goat anti-rabbit IgG
 .BiorCan Scientific, Mississauga, Ontario were used
as second antibodies, both at a dilution of 1:2000.
2.6. Zymography
The zymographic analysis was carried out essen-
w xtially as we previously described 28 . SDS-poly-
 . w xacrylamide 10% gels 29 were co-polymerized with
gelatin or casein both at a final concentration of 1
mgrml or with human placental type IV collagen at a
concentration 0.4 mgrml. The concentrated condi-
 .tioned media were mixed 3:1 vrv with sample
buffer 0.3 M Tris-HCl, pH 6.8, containing 8% SDS,
.0.4% bromophenol blue and 40% glycerol , loaded
onto the gels without boiling and separated by elec-
trophoresis. The gels were washed for 1 h in a
solution of 2.5% Triton X-100 in 40 mM Tris-HCl,
pH 7.6, and for 15 min in 10 mM Tris-HCl, pH 8.
For the enzymatic reaction to take place, the gels
were incubated for 18 h at 378C in a solution of 50
mM Tris-HCL, pH 8, containing 10 mM CaC1 . The2
gels were stained for 2 h in a 0.5% Coomassie blue
R250 solution, then destained in 20% methanol with
 .10% acetic acid until clear bands indicating lysis
were apparent on the blue background. Prestained
molecular weight markers were resolved on the same
gels, separated from other samples after electrophore-
sis and fixed in 5% acetic acid. To characterize the
protease bands, some of the gels were incubated in a
 .buffer 50 mM Tris-HCl, pH 8, with 10 mM CaC12
containing 20 mM EDTA a metalloproteinase in-
.hibitor .
2.7. In˝asion assays
The chemoinvasion assays were performed using 8
mm polycarbonate filters coated with reconstituted
basement membrane Matrigel; Collaborative Re-
( )M. Durko et al.rBiochimica et Biophysica Acta 1356 1997 271–280274
.  .search , type I rat tail; Boehringher-Manneheim or
 .type IV human placenta; Sigma collagen. Prior to
coating, Matrigel was diluted with cold distilled wa-
ter and 13 mg in 60 ml were added to each filter.
Type IV collagen was diluted in 0.1% acetic acid and
used at concentrations of 40–400 mg per filter. Be-
cause of batch-to-batch variations, preliminary tests
were performed for each batch of commercially ob-
tained pepsin-extracted type IV collagen, and the
collagen concentration readjusted to standardize the
assay conditions in respect to the levels of invasion
of control cells. Type I collagen was soaked overnight
in 0.1% acetic acid, mixed with 10=concentrated
PBS and 0.1 N NaOH at a ratio of 8:1:1 and added to
the filters at the indicated concentrations. The coated
filters were dried overnight and equilibrated with
serum-free RPMI for 2 h. The medium was then
removed, the filters placed in 24-well plates and to
each filter 5=104 cells were added in 100 ml RPMI
containing 0.2% BSA for a 48 h incubation at 378C,
in a humidified 5% CO incubator. To block metallo-2
proteinase activity, the synthetic peptidylhydroxamate
w . w  .inhibitor U24522 R,S -N- 2- hydroxyamino -2-
xoxoethyl -4-methyl-1-oxopentyl-L-leucyl-L-phenylala-
x w xninamide 30 generously provided by Dr. G. Di-
pasquale Stuart Pharmaceuticals, Wilmington
.Delaware was added with the cells at concentrations
of 40–80 mM which were predetermined to have no
cytotoxic effect. Human fibronectin 5 mgrml in
.RPMI was used as a chemoattractant in the lower
chamber. At the end of the incubation period, the
cells on the upper surface of the filters were removed
with a cotton swab and the filters fixed in 0.1%
glutaraldehyde and stained with 0.2% crystal violet.
The number of cells that migrated to the lower side
of the filter was counted using a Nikon inverted
 .microscope 400= . A total of 20 random fields
were counted per filter and 2 filters were used for
each assay condition. Migration assays were carried
out in a similar manner using filters which were
pre-coated with a low concentration of type IV colla-
 . w xgen 7.5 mgrfilter to facilitate cell spreading 28 .
3. Results
To assess the role of metalloproteinases in
melanoma MIM invasion, the cells were added to
Matrigel-coated filters together with the synthetic
metalloproteinase inhibitor U24522 at concentrations
 .40–80 mM predetermined to have no cytotoxic
effect on the cells. Results shown in Fig. 1 demon-
strate that this inhibitor blocked cell invasion in a
dose dependent manner by up to 55% and confirm
the involvement of metalloproteinases in the inva-
sion.
MIM cells constitutively express both MMP-1 and
MMP-2. To analyse the role of MMP-1 in the inva-
sion, MIM cells were transfected with a pSVK3
plasmid expressing a 777 bp MMP-1 insert in the
sense or antisense orientations relative to the SV-40
promoter. Several clones were obtained and the ex-
tent of MMP-1 mRNA suppression was evaluated by
the Northern blot assay. Two clones, 25-2 and 25-12,
which had marked reductions in MMP-1 mRNA lev-
 .els Fig. 2, panel a were selected for further analysis.
The reductions in the MMP-1 mRNA transcripts in
these clones as calculated by comparison to MIM
wild-type cells and standardized relative to the 18S
rRNA were 90% and 96% respectively. In these
clones, as well as in the sense-transfected clone 7-1,
the mRNA levels for MMP-2 were either unchanged
or slightly higher than in the wild-type cells Fig. 2,
.panel b .
To assess MMP-1 expression at the protein level, a
Western blot analysis was performed. A single, Mr
48 000 band corresponding to the active form of
Fig. 1. Inhibition of MIM invasion by the metalloproteinase
inhibitor U24522. MIM cells were added to the Matrigel-coated
 4 .filters 5=10 cellsrfilter with or without the indicated concen-
trations of the inhibitor. Invasion was analyzed following a 48 h
incubation at 378C. The results are expressed as the percent of
invading cells relative to control MIM cells.
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MMP-1 was seen in blots prepared from medium
conditioned by wild-type MIM cells. This band could
not be detected in parallel blots of conditioned media
derived from either one of the transfectants, confirm-
ing that MMP-1 protein synthesis in these cells was
 .also suppressed Fig. 3 .
Suppression of MMP-1 production was also con-
firmed at the functional level. When the ability of
25-12 cells to degrade type I collagen was measured
using 8 mm filters precoated with graded concentra-
tions of type I collagen, we found that the relative
invasiveness of the transfectants decreased with in-
Fig. 2. Northern blot analysis of MMP-1 and MMP-2 mRNA in antisense-transfected cells. Fifteen mg of total RNA were loaded in each
lane. a: The blots were hybridized first with an oligonucleotide probe specific for MMP-1 and then with an oligonucleotide probe for 18S
rRNA. Lane 1: wilde-type MIM cells, Lane 2: sense-transfected clone 7-1, Lanes 3 and 4: antisense-transfected clones 25-2 and 25-12. b:
The blots were hybridized successively with the 1.1 kb cDNA fragment of MMP-2 and an 18S rRNA-specific oligonucleotide probe.
Lane 1: sense-transfected clone 7-1; Lanes 2 and 3: antisense-transfected clones 25-2 and 25-12. The results of the densitometry are
shown in the bar graph. All values have been normalized relative to MIM wild-type cells which were assigned a value of 1.
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Fig. 3. Western blot analysis of MMP-1. Conditioned media
 .  .derived from wild-type MIM lanes 1,2 , clone 25-12 lane 3
 .  .and clone 25-2 lane 4 cells were concentrated =50 and the
 .proteins 10 mg per lane resolved on 10% SDS-polyacrylamide
gel and transferred to a nitrocellulose filter. The filters were
probed with a mouse monoclonal antibody to MMP-1 lanes
.  .2,3,4 and normal mouse serum lane 1 , as control. The positions
 y3.of MW markers =10 are shown on the left. The position of
the active form is indicated with an arrow on the right.
creasing concentrations of collagen reaching 20% of
control levels at a concentration of 40 mg type I
 .collagen Fig. 4 .
In order to analyse the expression and function of
MMP-2 in the transfected cells, gel zymography and
a Western blot analysis were subsequently performed.
Fig. 4. Loss of type I collagen degradation and invasion in cells
expressing MMP-1 antisense mRNA. Wild-type MIM and anti-
sense transfected clone 25-12 cells were seeded onto filters
 4 .5=10 cellsrfilter precoated with collagen at the indicated
concentrations. Incubation was for 48 h at 378C. Shown are
 .means and SD of 3 experiments each performed in duplicates.
Invasion of 25-12 cells was significantly lower than that of MIM
cells P -0.05, P -0.025 and P -0.01 for 10, 20 and 40 mg
.type I collagen, respectively .
When serum-free conditioned media derived from
MIM and transfected cells were analysed on poly-
acrylamide gels co-polymerized with 1 mgrml
gelatin, several bands of lysis were observed in all
 .the zymograms Fig. 5, panel a . These gelatinolytic
activities were completely inhibited when the gels
were incubated in the presence of 20 mM EDTA not
.shown indicating that they were mediated by metal-
loproteinases.
Two of the bands migrated in the M 66–72 000r
region corresponding to the predicted molecular
weights for MMP-2. These bands were of comparable
intensities in all the zymograms suggesting that the
functional levels of this gelatinase were unaltered.
When an anti-MMP-2 antibody was subsequently
used to analyse conditioned media derived from
clones 25-2 and 25-12 in a Western blot assay, a 66
kDa band corresponding to the active form of MMP-2
 .was detected Fig. 6 . Consistent with the zymogra-
 .phy results Fig. 5, panel a , the MMP-2 protein
bands seen on Western blots of conditioned media
derived from antisense-transfected and control cells
were of comparable intensities.
Two weak gelatinolytic bands of 57 and 54 kDa
were also observed in all the zymograms. This
molecular mass range is characteristic of the proen-
w xzyme forms of MMP-1 and stromelysin 7,11,31 .
However, these bands were not detectable in Western
blots probed with an antibody to the C-terminal
w xdomain of MMP-1 27 , suggesting that they were
probably due to stromelysin activity. Moreover,
Fig. 5. Analysis of proteinase activity in MIM cells by gel
zymography. Serum-free conditioned media derived from wild-
 .  .  .type MIM lanes 1,5 , clone 7-1 lane 2 , clone 25-2 lanes 3,7
 .  .and clone 25-12 lanes 4,6 cells were concentrated =100 and
 .the proteins 25 mgrlane resolved on 10% SDS-polyacrylamide
 .gels which were co-polymerized with 1 mgrml gelatin panel a
 .  y3.or casein panel b . The positions of MW markers =10 are
shown on the left.
( )M. Durko et al.rBiochimica et Biophysica Acta 1356 1997 271–280 277
Fig. 6. Western blot analysis of MMP-2. Conditioned media
 .  .derived from wild-type MIM lanes 1,2 , clone 25-12 lane 3
 .  .and clone 25-2 lane 4 cells were concentrated =50 and the
proteins resolved on 10% SDS-polyacrylamide gel and trans-
ferred to nitrocellulose filters. The filters were probed with a
 .rabbit antiserum to MMP-2 lanes 2,3 and 4 or normal rabbit
 .serum as control lane 1 both at a dilution of 1:250. The
 y3.positions of MW markers =10 are shown on the left. The
position of the active intermediate is indicated with an arrow on
right.
MMP-1 is known to have poor gelatinolytic activity
w x32,33 and stromelysin has been shown to produce
more prominent zones of lysis on casein than on
w xgelatin substrate gels 34 . When the intensities of
these bands on both types of gels were compared, we
found that the gelatinolytic activities associated with
these weak zones of lysis resulted in more prominent
 .casein degradation Fig. 5, panel b , consistent with
the conclusion that they were produced by
stromelysin. The additional bands which became visi-
ble on the casein-containing gels 42–45 kDa, see
.Fig. 5, panel b may represent the activated forms of
w xstromelysin 7 .
Subsequently, the invasive abilities of the transfec-
tants were analysed using 8 mm filters precoated
with type IV collagen or Matrigel. We observed a
marked reduction in the abilities of 25-2 and 25-12
cells to invade through type IV collagen or Matrigel-
coated filters as compared to control, wild-type cells
 .Fig. 7 . Cell migratin as measured on uncoated
 .filters not shown or on filters precoated with 7.5
 .mgrfilter type IV collagen Fig. 7 was comparable
to that of control cells.
To assess type IV collagen degradation in a more
direct manner, zymography was performed using
polyacrylamide gels co-polymerized with placental
type IV collagen. We found that conditioned medium
derived from wild-type MIM cells produced a zone
of lysis in the M 66–68 000 region corresponding tor
the predicted molecular weight range for activated
Fig. 7. Suppression of type IV collagen and Matrigel invasion in
melanoma cells expressing MMP-1 antisense mRNA. Antisense
 .  .transfected 25-2 open bars and 25-12 solid bars and sense
 .transfected 7-1 shaded bars cells were seeded onto the coated
filters at a density of 5=104 cellsrfilter. Invasion was measured
following a 48 h incubation at 378C. The results are expressed as
percent of invading cells relative to control, wild-type MIM cells
which were included in every experiment and represent means
 .and SD of 2–3 experiments. The invasion of 25-2 and 25-12
cells was significantly lower than that of MIM cells on filters
 .precoated with type IV collagen P -0.05 and P -0.005 or
 .Matrigel P -0.01 and P -0.0005, respectively . Filters pre-
coated with 7.5 mg type IV collagen were used as migration
controls.
MMP-2. This zone of lysis was either not apparent or
considerably diminished in zymograms of condi-
 .tioned media from clones 25-12 and 25-2 Fig. 8 .
Fig. 8. Zymographic analysis of the type IV collagenolytic
activity in MIM cells. Serum-free conditioned media derived
 .  .from wild-type MIM lane 1 , clone 25-2 lane 2 and clone
 .  .25-12 lane 3 cells were concentrated =100 and the proteins
 .20mgrlane resolved on 10% SDS-polyacrylamide gels which
were co-polymerized with 0.4 mgrml placental type IV collagen.
 y3.The positions of MW markers =10 are shown on the left.
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4. Discussion
The dissolution of basement membrane barriers is
a key event in cancer dissemination and metastasis. A
number of proteinases have been implicated in tumor
w xinvasion 2,9,35 and their expression appears to vary
w xin different tumor types 15,19,20,36 . In melanoma
cells MMP-1, MMP-2 and MMP-9 were shown to be
w xconstitutively upregulated 19,33,37 . However, the
relative contributions of these enzymes to melanoma
invasion and metastasis are not fully understood.
In the present study, an invasive, human melanoma
cell line, MIM, in which both MMP-1 and MMP-2
are constitutively expressed was used. To analyse the
role of MMP-1 in invasion in this model, its expres-
sion was suppressed by stable transfection with a
plasmid vector expressing an MMP-1 DNA fragment
in the antisense orientation relative to the promoter.
As expected, we found that melanoma cells in which
MMP-1 mRNA levels were greatly reduced, lost their
ability to invade through a matrix barrier composed
of type I collagen. The surprising finding was that
these cells also had a significantly reduced ability to
invade through type IV collagen and a reconstituted
 .basement membrane Matrigel in which type IV
w xcollagen is the major matrix constituent 38 . This
reduction was seen despite the unaltered high produc-
tion of MMP-2 by these cells as confirmed at both
the mRNA and protein levels and despite the appar-
ent expression of stromelysin-1, as suggested by the
results of zymography with casein-containing gels.
We observed that the level of MMP-1 mRNA in
the sense-transfected clone 7-1 cells was lower 40%
.reduction than in the MIM wild-type cells. The
reason for this difference is not clear. It may suggest
that within the wild-type MIM cell line, clonal sub-
populations express variable levels of this enzyme
and the selected clone 7-1 was at the low end of this
spectrum. Alternatively, this reduction may have re-
sulted from the transfection and may possibly be
related to the site of DNA integration. However, as
the invasion of clone 7-1 cells on all the matrices
tested was comparable to control MIM cells, it ap-
pears that this reduction in mRNA levels was not
sufficient to significantly impact on the matrix-de-
grading ability of the cells.
Several mechanisms may be invoked in interpret-
ing our data. MMP-1, whose main function is thought
to be the dissolution of fibrillar type I and III colla-
w xgens by cleaving at a site within the triple helix 2
has also been reported to degrade full length type IV
w xcollagen 32 . On the other hand MMP-2 and MMP-9
have been shown to degrade only pre-cleaved or
conformationally altered forms of type IV collagen
w x39,40 , prompting the suggestion that they may not
be true type IV collagenases but may in fact act
secondarily to other enzymes and mediate further
degradation of an already processed type IV collagen
w x39 . It is possible, therefore, that in MIM cells,
MMP-1 acts initially to degrade the native type IV
collagen while the gelatinases only complete the
degradative process. In cells which do not elaborate
the required levels of MMP-1, this process may be
blocked and the catalytic activity of the gelatinases
may be insufficient to degrade the basement mem-
brane structure. This interpretation is compatible with
our observation that there was no apparent reduction
in the gelatinolytic activities detected in conditioned
media of the antisense-transfectants as measured by
zymography, while the same cells had a significantly
reduced ability to degrade type IV collagen or Ma-
trigel. It is also in accord with our finding that a
prominent zone of lysis corresponding to active forms
of MMP-2 was present in type IV collagen zymo-
grams obtained from medium conditioned by MIM
cells but was diminished or absent in media condi-
tioned by 25-2 or 25-12 cells.
Another possibility is that MMP-1 and MMP-2
may be involved in a proteolytic cascade where
activation of the latter requires the catalytic action of
w xthe former 41 and the process is blocked when
MMP-1 levels are sufficiently reduced. Proteolytic
cascades involving members of the same or different
families of matrix-degrading proteinases have been
w xdescribed in other tumor models 42 . However this
mechanism may not be critical in the present model
because the active, 66 kDa form of MMP-2 could be
found in conditioned media derived from the anti-
sense-transfectants. This suggests that MMP-2 activa-
tion could proceed in the absence of MMP-1, possi-
bly through the proteolytic activity of other metallo-
w xproteinases 43,44 .
We found that wild-type MIM cells and the trans-
fectants produced low and comparable levels of
 .TIMP-1 data not shown suggesting that suppression
of MMP-1 transcription did not directly affect the
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synthesis of the inhibitor. This raises the possibility
that in the transfectants, the decrease in MMP-1
levels may have resulted in an increased level of
unbound TIMP which could block the activity of
 .other metalloproteinases e.g., MMP-2 . While we
cannot entirely ruled out the possibility that a change
in the TIMP:enzyme ratio had an effect on net prote-
olysis, two observations suggest that this was not a
 .major mechanism: 1 a reduction in collagenolytic
activity was seen in type IV collagen zymograms
obtained with conditioned media from 25-2 and 25-12
 .cells Fig. 8 , despite the dissociation of TIMP and
.metalloproteinases under the assay conditions and b
antisense transfected clones in which the suppression
of MMP-1 mRNA expression was only partial 50–
.70% , had unaltered levels of type IV collagen degra-
 .dation and invasion data not shown . The latter
observation indicates that suppression of type IV
collagen degradation was not proportional to the in-
crease in the TIMP:metalloproteinase ratio and sug-
gests that total inhibition of MMP-1 synthesis such
xas was seen in clone 25-12 was required to achieve a
significant suppression of type IV collagen degrada-
tion and invasion.
While the precise contribution of MMP-1 to type
IV collagen degradation remains to be elucidated, our
results suggest that the upregulated expression of this
enzyme in vivo during the course of melanoma pro-
gression may not only provide the cells with a prote-
olytic mechanism for dissolution of dermal collagen
during the vertical growth phase, but may also en-
hance basement membrane degradation which is re-
quired for blood vessel invasion and dissemination to
distant organs. This enzyme may therefore provide an
effective target for specific therapeutic intervention in
the progression of melanoma metastasis.
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